Cullinan Associates Inc Merck & Co., Inc. Transaction History

Cullinan Associates Inc

  • $1.76 Billion
  • Q1 2024

A detailed history of Cullinan Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cullinan Associates Inc holds 40,248 shares of MRK stock, worth $5.14 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
40,248
Previous 58,979 31.76%
Holding current value
$5.14 Million
Previous $6.43 Million 17.41%
% of portfolio
0.3%
Previous 0.36%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024
SELL
$113.24 - $131.95 $2.12 Million - $2.47 Million
-18,731 Reduced 31.76%
40,248 $5.31 Million
Q4 2023

Jan 24, 2024
SELL
$100.18 - $109.02 $629,531 - $685,081
-6,284 Reduced 9.63%
58,979 $6.43 Million
Q3 2023

Oct 11, 2023
SELL
$102.95 - $114.33 $667,218 - $740,972
-6,481 Reduced 9.03%
65,263 $6.72 Million
Q2 2023

Jul 14, 2023
SELL
$108.61 - $118.38 $554,128 - $603,974
-5,102 Reduced 6.64%
71,744 $8.28 Million
Q1 2023

Apr 05, 2023
BUY
$102.94 - $114.86 $2.07 Million - $2.31 Million
20,104 Added 35.43%
76,846 $8.18 Million
Q4 2022

Jan 11, 2023
BUY
$87.44 - $112.11 $255,587 - $327,697
2,923 Added 5.43%
56,742 $6.3 Million
Q3 2022

Oct 19, 2022
BUY
$84.53 - $94.96 $615,040 - $690,928
7,276 Added 15.63%
53,819 $4.64 Million
Q2 2022

Jul 08, 2022
SELL
$83.49 - $94.64 $454,185 - $514,841
-5,440 Reduced 10.46%
46,543 $4.24 Million
Q1 2022

Apr 21, 2022
BUY
$73.51 - $82.4 $695,404 - $779,504
9,460 Added 22.25%
51,983 $4.27 Million
Q4 2021

Jan 07, 2022
SELL
$72.28 - $90.54 $4.93 Million - $6.18 Million
-68,210 Reduced 61.6%
42,523 $3.26 Million
Q3 2021

Oct 08, 2021
SELL
$71.68 - $78.83 $74,977 - $82,456
-1,046 Reduced 0.94%
110,733 $8.32 Million
Q2 2021

Jul 07, 2021
SELL
$70.31 - $77.77 $1.12 Million - $1.24 Million
-16,000 Reduced 12.52%
111,779 $8.69 Million
Q1 2021

Apr 20, 2021
SELL
$68.86 - $81.11 $26,511 - $31,227
-385 Reduced 0.3%
127,779 $9.85 Million
Q4 2020

Jan 14, 2021
BUY
$71.77 - $79.65 $264,328 - $293,350
3,683 Added 2.96%
128,164 $10.5 Million
Q3 2020

Oct 09, 2020
BUY
$73.18 - $82.95 $2.02 Million - $2.29 Million
27,575 Added 28.46%
124,481 $10.3 Million
Q2 2020

Jul 07, 2020
SELL
$70.42 - $80.13 $797,154 - $907,071
-11,320 Reduced 10.46%
96,906 $7.49 Million
Q1 2020

Apr 01, 2020
SELL
$63.36 - $87.82 $221,063 - $306,403
-3,489 Reduced 3.12%
108,226 $8.33 Million
Q4 2019

Jan 15, 2020
SELL
$77.58 - $87.54 $96,276 - $108,637
-1,241 Reduced 1.1%
111,715 $10.2 Million
Q3 2019

Oct 01, 2019
SELL
$76.08 - $82.93 $15,216 - $16,586
-200 Reduced 0.18%
112,956 $9.51 Million
Q2 2019

Jul 16, 2019
SELL
$69.84 - $81.59 $492,372 - $575,209
-7,050 Reduced 5.86%
113,156 $9.49 Million
Q1 2019

Apr 30, 2019
BUY
$69.58 - $79.36 $100,891 - $115,072
1,450 Added 1.22%
120,206 $10 Million
Q4 2018

Jan 11, 2019
SELL
$65.24 - $75.71 $257,697 - $299,054
-3,950 Reduced 3.22%
118,756 $9.07 Million
Q3 2018

Oct 19, 2018
SELL
$57.69 - $67.84 $2.02 Million - $2.37 Million
-35,000 Reduced 22.19%
122,706 $8.71 Million
Q2 2018

Jul 09, 2018
SELL
$50.83 - $59.72 $345,644 - $406,096
-6,800 Reduced 4.13%
157,706 $9.57 Million
Q1 2018

Apr 27, 2018
SELL
$50.96 - $59.23 $28,282 - $32,872
-555 Reduced 0.34%
164,506 $8.96 Million
Q4 2017

Jan 17, 2018
SELL
$51.62 - $61.64 $3.37 Million - $4.02 Million
-65,200 Reduced 28.32%
165,061 $9.29 Million
Q3 2017

Oct 16, 2017
BUY
$58.67 - $63.13 $13.5 Million - $14.5 Million
230,261
230,261 $14.7 Million

Others Institutions Holding MRK

# of Institutions
3,767
Shares Held
1.87B
Call Options Held
17.3M
Put Options Held
14.8M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email